Medical Biomonitoring of Maternal and Fetal Exposure to Carbon Monoxide and its Modification by Demographic and Obstetric Characteristics
Main Article Content
Keywords
Medical Biomonitoring, Maternal and Fetal Exposure, Carbon Monoxide, Modification, Characteristics
Abstract
Background: There is a paucity of organized human biomonitoring, including that of carbon monoxide (CO) in the Niger Delta, Nigeria. The study aims to quantify the impact of maternal exposure to CO in the first trimester of pregnancy and its modification by maternal demographic and obstetric factors.
Methodology: It was of cross-sectional design conducted at the Rivers State University Teaching Hospital (RSUTH) in Nigeria. Four hundred and ninety consecutive pregnant women in the first trimester were recruited from the antenatal clinic from January 2021 to January 2022. Demographic, social, and obstetric characteristics were recorded. Maternal exhaled CO concentration (ECOC) and maternal and fetal carboxyhaemoglobin concentrations (MCOHC and FCOHC) were measured with the aid of a smokelyzer. Data were analyzed, using SPSS version 25.0 software. Ethical approval was obtained from the RSUTH Ethics Committee.
Results: The mean values of ECOC, MCOHC, and FCOHC were 3.25±2.51 ppm, 1.15±0.40%, and 0.93±0.72% respectively and the severity (mild, moderate, and severe) of the impact was inversely proportional to the number of women affected. There were statistically significant differences in the mean values of ECOC, MCOHC, and FCOHC in the following maternal characteristics: age, educational levels, BMI, gravidity, and parity. In the case of FCOHC, the measures of the differences were as follows: p:<0.019, <0.020, <0.0001, <0.0001, and <0.038 for age categories, educational levels, BMI, gravidity, and parity respectively. There were statistically significant positive correlations between the BMI and the mean values of ECOC, MCOHC, and FCOHC.
Conclusion: The higher the severity of exposure to CO (mild, moderate, and severe), the lower the number of impacted pregnant women. There were statistically significant differences in the mean values of ECOC, MCOHC, and FCOHC in women of different ages, educational levels, BMI, gravidity, and parity categories.
References
2. Gomez C, Berlin I, Marquis P, Delcroix M. Expired air carbon monoxide concentration in mothers and their spouses above 5 ppm is associated with decreased fetal growth. Prev Med 2005;40(1):10-15.
3. Dalhamn T, Edfors M L, Rylander R. Retention of cigarette smoke components in human lungs. Archives of Environmental Health: An International Journal 1968; 17(5):746-748.
4. Silverman RK, Montano J. Hyperbaric oxygen treatment during pregnancy in acute carbon monoxide poisoning. A case reports. The Journal of Reproductive Medicine 1997; 42(5):309-311.
5. Woody RC, Brewster MA. Telencephalic dysgenesis associated with presumptive maternal carbon monoxide intoxication in the first trimester of pregnancy. Journal of Toxicology Clinical Toxicology 1990; 28(4):467-475.
6. Singh J. Early behavioral alterations in mice following prenatal carbon monoxide exposure. Neurotoxicology 1986; 7(2):475-481.
7. Bailey LTJ, Johnston MC, Billet J. Effects of carbon monoxide and hypoxia on cleft lip in A/J mice. The Cleft palate-craniofacial journal 1995; 32(1):14-19.
8. Tachi N, Aoyama M. Effect of cigarette smoke and carbon monoxide inhalation by gravid rats on the conceptus weight. Bulletin of Environmental Contamination and Toxicology 1983; 31(1):85-92.
9. Osborne JS, Adamek S, Hobbs ME. Some components of gas phase of cigarette smoke. Analytical Chemistry 1956; 28(2):211-215.
10. Cramer CR. Fetal death due to accidental maternal carbon monoxide poisoning. Journa of Toxicology: Clinical Toxicology 1982; 19(3):297-301.
11. Farrow JR, Davis GJ, Roy TM, McCloud LC, Nichols GR. Fetal death due to nonlethal maternal carbon monoxide poisoning. Journal of Forensic Science, 1990; 35(6):1448-1452.
12. Mkpe Abbey, Oloyede O. Adebari, Kinikanwo I. Green, Bruno C. Chinko. Carbon Monoxide (CO) Pollution in the Niger Delta area of Nigeria and Its Impact on Feto-Maternal Health. Sch Int J ObstetGynec2022; 5(2): 57-64.
13. Abbey M, Amadi SC, Ocheche US, Wekere FCC, Altraide BO, Oloyede OA, et al. Maternal exposure to carbon monoxide in the first trimester (7-13+6 weeks) of pregnancy in the core Niger Delta. Int J Reprod Contracept ObstetGynecol2022; 11(7):1839-1847.
14. Abbey M, Amadi C. S, Alpheaus MBA, Kwosah NJ, Nonye-Enyidah E, Kua P, Okagua Kenneth. Human Biomonitoring of Maternal exposure to Carbon Monoxide in the First Trimester of Pregnancy in the Core Niger Delta. Sch Int J Obstet Gynec 2022; 5(5): 272-280.
15. Abbey M, Amadi SC, Mba AG, Kwosah NJ, Altraide BO, Sapira-Ordu L, Nonye-Enyidah E, Akani CI.Biomonitoring of Fetal Exposure to Carbon Monoxide in the First Trimester of Pregnancy in the Core Niger Delta. Scholars International Journal of Obstetrics and Gynecology 2022; 5(5): 261-271.
16. Smokerlyzer. Bedfont www.bedfont.com. 1996.
17. Jarvis MJ, Belcher M, Vesey C, Hutchison DCS. Low-cost carbon monoxide monitors in smoking assessment. Thorax 1986; 41:886-887.
18. Gomez C, Berlin I, Marquis P, Delcroix M. Expired air carbon monoxide concentration in mothers and their spouses above 5ppm is associated with decreased fetal growth. Preventive Medicine 2005; 40:10-15
19. Wylie BJ, Kishashu Y, Matechi E, Zhou Z, Coull B, Abioye AI, Dionisio KL, Mugusi F, Premji Z, Fawzi W, Hauser R, Ezzati M. Maternal exposure to carbon monoxide and fine particulate matter during pregnancy in an urban Tanzanian cohort. Indoor Air2017 ;27(1):136-146.
20. Ciara ME Reynolds, Brendan Egan, Rachel A. Kennedy, Eimer O’Malley, Sharon R. Sheehan, Michael J. Turner. The implications of high carbon monoxide levels in early pregnancy for neonatal outcome. European Journal of Obstetrics & Gynecology and Reproductive Biology2019; 233:6-11.
21. Bruce MC, Bruce EN. Analysis of factors that influence rates of carbon monoxide uptake, distribution, and washout from blood and extravascular tissues using a multicompartment model. Journal of Applied Physiology2006; 100:1171–1180.
22. Coburn RF, Forster RE, Kane PB. Considerations of the physiological variables that determine the blood carboxyhemoglobin in concentration in man. Journal of Clinical Investigation 1965; 44:1899–1910.
23. Raub JA, Benignus VA. Carbon monoxide and the nervous system. Neuroscience and Biobehavioral Reviews 2002; 26:925–940.
24. Scherer G. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Experimental and Toxicological Pathology 2006; 58:101– 124.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.